700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ ReadersThis Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Head Translational Patient Safety
AstraZeneca Research & Development,
Global Medicines Development, Sweden
Dr. Steffen W. Ernst joined AstraZeneca R&D Sweden in October 2002 and held various different roles in Pre-clinical Safety, and now heading the Global Section of Translational Patient Safety. Dr. Steffen W. Ernst aligning his training in Toxicology and medical background to develop the important area of Translational Medicine. Prior to joining AZ, Dr. Steffen W. Ernst worked >10 years in various other pharmaceutical companies (Hoechst, Boehringer-Ingelheim, Pfizer) as well as at the University of Munch Medical Centre. Dr. Steffen W. Ernst conducted his PhD training in Toxicology at the University of Kansas Medical Centre, USA and the German Gesellschaft für Umwelt und Gesundheit in Munich, Germany and received his medical degree from the Ludwig-Maximilian University in Munich, Germany. Dr. Steffen W. Ernst is US Board certified in Toxicology since 2001 and a EU registered Toxicologist through the British Toxicology Society since 2002.
Global Speakers in the subject
Global Experts in the subject